PATENT CLAIM ANALYSIS

Application Number: 15761754
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["544", "249000"]

Abstract:
This invention provides novel processes for the preparation of compounds such as 3-[(1S,2S)-2-hydroxycyclohexyl]-6-[(6-methylpyridin-3-yl)methyl]benzo[h]-quinazolin-4(3H)-one, salts and derivatives thereof. The compounds synthesized by the processes of the invention are useful for treating Alzheimer's disease and other diseases (e.g., cognitive impairment, schizophrenia, pain disorders, and sleep disorders) mediated by the muscarinic M1 receptor.

Claim (Index 31):
The process of  claim 22  wherein alkylation is performed using step (2).

Metadata:
- Claim Count in Document: 62.0
- Percentile: 90.0
- Lexical Diversity: 1.49091
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13704259', '13703983', '13825137', '13805346', '14117265']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7299281507267845
- 35 USC 102 Novelty (BERT): 0.523339683316361
- Combined Prediction Score: 0.7092693039857422
- Mean Citation Score: 195.878918
- Max Citation Score: 200.08705
- Similarity Product: 96.43930916618108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test